(19)
(11) EP 4 069 674 A1

(12)

(43) Date of publication:
12.10.2022 Bulletin 2022/41

(21) Application number: 21749519.1

(22) Date of filing: 14.07.2021
(51) International Patent Classification (IPC): 
C07C 323/60(2006.01)
A61P 19/02(2006.01)
A61K 31/198(2006.01)
A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
C07C 323/60; A61P 31/14; A61P 19/02; C07B 2200/13; C07B 2200/07
(86) International application number:
PCT/IB2021/056324
(87) International publication number:
WO 2022/153101 (21.07.2022 Gazette 2022/29)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 12.01.2021 IN 202141001488

(71) Applicant: OPTIMUS DRUGS PRIVATE LIMITED
TELANGANA, 500084 (IN)

(72) Inventors:
  • SRINIVAS REDDY, Desi Reddy
    Hyderabad, Telangana, 500084 (IN)
  • SUBBA REDDY, Peketi
    Hyderabad, Telangana, 500084 (IN)
  • PITCHI REDDY, Chaganti
    Hyderabad, Telangana, 500084 (IN)

(74) Representative: Hamm&Wittkopp Patentanwälte PartmbB 
Jungfernstieg 38
20354 Hamburg
20354 Hamburg (DE)


(56) References cited: : 
   
       


    (54) CRYSTALLINE FORM I OF BUCILLAMINE